You are here

Inctye

Despite recent progress, Incyte still far off from pricing goal for key eczema launch Opzelura

Fierce Pharma

Tue, 11/1/22 - 06:59 pm

Positive momentum for biotech Incyte

GoinPharma

Thu, 03/29/18 - 09:30 pm

rheumatoid arthritis

Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain

Motley Fool

Mon, 04/17/17 - 12:09 pm

rheumatoid arthritis

Incyte grabs control of a cancer drug from Calithera’s pipeline for $53M up front

Endpoints

Mon, 01/30/17 - 10:19 am

immuno-oncology